Hillstream BioPharma, Inc. (NASDAQ:HILS – Get Free Report)’s stock price was down 1.7% during trading on Thursday . The stock traded as low as $2.94 and last traded at $2.94. Approximately 152,323 shares traded hands during mid-day trading, a decline of 89% from the average daily volume of 1,388,685 shares. The stock had previously closed at $2.99.
Hillstream BioPharma Stock Performance
The company’s 50 day moving average price is $2.91 and its 200 day moving average price is $2.01. The company has a market cap of $51.75 million, a price-to-earnings ratio of -4.08 and a beta of 3.08.
Hillstream BioPharma Company Profile
Hillstream BioPharma, Inc, a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors.
Featured Stories
- Five stocks we like better than Hillstream BioPharma
- 3 Fintech Stocks With Good 2021 Prospects
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- Dividend Capture Strategy: What You Need to Know
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- Retail Stocks Investing, Explained
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for Hillstream BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hillstream BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
